Interestingly, an intriguing association between TRPM8 overexpression and a strong in vivo reduction in VEGF and microvascular density (MVD) has been reported [14], thus highlighting a possible additional TRPM8–mediated, anti–angiogenic contribution to the observed reduction in tumor growth in vivo. The gene discussed is TRPM8; the disease is neoplasm.